Foot Well in the Western Haynesville in Texas to Accelerate Revenue Development

Empire Petroleum (NYSE American: EP) said it successfully re-entered and evaluated the Wakefield-Harrison GU B #1 well in Fort Trinidad, Texas, reaching 21,006 feet measured depth (20,949 feet TVD). The company reported modern open-hole logs and sidewall cores, with gas and liquids shows, and said the work cost about $4.4 million. The well is not completed or production tested.

Original reporting
Published Aug 17, 2026, 9:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 11:21 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefTechnology
Primary signal
$EP
Bullish
medium confidence
Mentioned
$EP
Relevance
7/10
alphai data visualization · based on markets.financialcontent.com
Decision brief

The 30-second read

$EPBullishMed
01

Why it matters

The company claims a record-depth modern evaluation via re-entry, providing new subsurface control and data to reprocess 3D seismic and plan future horizontal laterals.

02

Market read

This is a technical milestone that can improve perceived de-risking for Empire’s deep-gas roadmap, but it lacks production or reserve confirmation.

03

What to watch

Hydrocarbon shows and core recovery do not guarantee deliverability; the next two deepening wells and any reprocessed seismic improvements are the real gating items for valuation rerating.

Relevance 7/10Novelty 7/10Timing: today’s PR on a newly completed re-entry and subsurface evaluation

Background

Empire Petroleum is advancing a Texas gas development program in the Fort Trinidad field, targeting deeper intervals within the Western Haynesville play.

Company-level read

Ticker impact

$EPBullishMedium confidence
Context

Empire Petroleum announced a successful 21,006-foot re-entry and full open-hole log plus sidewall cores at the Wakefield-Harrison GU B #1 well in Texas.

Expected impact

Near-term upside bias for EP on technical progress, with follow-through likely contingent on results from the next two deepening wells and any eventual flow testing.

Evidence & confidence

The article provides new, specific well execution details (depth, logging suite, core recovery, shows) and positions it as foundational for future development, but explicitly states the well is not completed or production tested and no reserves/flow rates are reported.

Market effects

Highlights a cost-efficient re-entry approach versus new ultra-deep drilling in the Western Haynesville, potentially reinforcing investor interest in similar low-capex appraisal strategies.

Supports development momentum in the Fort Trinidad area of the Western Haynesville play in Madison County, Texas.

Limited direct global impact; relevance is primarily play-level and company-specific until production or reserves are quantified.

Counterpoint

Without completion, production testing, or reserve/resource estimates, the market may discount the news as appraisal-only and wait for flow rates or commercial confirmation.

Key entities

  • Empire Petroleum Corporation

    Announced successful re-entry and subsurface evaluation of the Wakefield-Harrison GU B #1 well, including open-hole logs and sidewall cores.

  • Fort Trinidad field

    Texas field where Empire is deepening wells to access stacked reservoirs and deeper Haynesville objectives.

  • Wakefield-Harrison GU B #1 well

    21,006-foot re-entry with modern open-hole logging suite and sidewall core recovery; not yet completed or production tested.

Related articles

$HIVEMedAI 8/10

Bitcoin miner HIVE inks five-year $350 million AI cloud contract, adds $70 million in annualized revenue

HIVE Digital Technologies said its BUZZ High Performance Computing unit signed a five-year, $350 million GPU cloud services contract with an unnamed investment-grade enterprise customer. HIVE expects about $70 million in annualized revenue and BUZZ HPC annualized revenue of about $180 million. The buildout will use 2,016 NVIDIA Blackwell Ultra GPUs and cost about $185 million, with delivery in Q4 2026.

$AZNMedAI 8/10

AstraZeneca halts lung cancer trial in fresh pipeline setback

AstraZeneca said it halted a late-stage phase three lung cancer trial of Volrustomig plus chemotherapy after an Independent Data Monitoring Committee review found it unlikely to improve survival versus existing treatments. The company noted it will continue Volrustomig studies in other cancers. Separately, it reported Enhertu progress in non-small cell lung cancer and Tagrisso plus Orpathys results, and shares rose up to 2%.

$LEUMed

Centrus Energy to make thousands of centrifuges in Oak Ridge | Exclusive

Centrus Energy says its Oak Ridge plant will ramp production of AC100M uranium enrichment centrifuges over the next three years, supporting HALEU output at its Piketon, Ohio facility. The company cites a $900 million DOE task order and a 16-centrifuge demo cascade. Centrus and Oklo plan HALEU deliveries starting 2029 for Oklo’s Aurora reactors.

$AAPLMed

Rothschild lifts Apple to Buy on foldable iPhone and AI strategy shift

Rothschild & Co Redburn upgraded Apple (AAPL) to Buy from Neutral and raised its price target to $400 from $260. The note cites a shift in Apple Intelligence, including reliance on Google’s Gemini (about $1B/year), and a planned foldable iPhone in September. It forecasts 14M iPhone Ultra units in FY2027 and expects higher iPhone revenue and earnings vs consensus, with risks from production and AI/model dependence.

$AZNMedAI 8/10

AstraZeneca ditches lung cancer treatment trial

AstraZeneca said it stopped a late-stage phase 3 trial of volrustomig plus chemotherapy for lung cancer after data review found it unlikely to improve survival versus existing treatments, following an Independent Data Monitoring Committee recommendation. The company noted it will keep developing volrustomig in other cancers and reported Enhertu phase 3 progress in non-small cell lung cancer. AZ shares rose about 2% early.